| 51 |
22668755 | Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia. | 2012 Nov |
2 |
| 52 |
21297370 | [Genetic marker of statin-induced rhabdomyolysis]. | 2011 Feb |
1 |
| 53 |
21945488 | Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP). | 2011 Nov 20 |
3 |
| 54 |
22216116 | Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites. | 2011 |
1 |
| 55 |
19543298 | The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells. | 2009 Jul |
1 |
| 56 |
19785645 | Impact of OATP transporters on pharmacokinetics. | 2009 Oct |
3 |
| 57 |
19833260 | The SLCO1B1*5 genetic variant is associated with statin-induced side effects. | 2009 Oct 20 |
1 |
| 58 |
20090898 | Pharmacogenomic insights into treatment and management of statin-induced myopathy. | 2009 Dec 29 |
1 |
| 59 |
23496050 | Towards companion diagnostics for the management of statin therapy. | 2009 Nov |
2 |
| 60 |
17470528 | Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. | 2007 Aug |
1 |
| 61 |
17108811 | SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. | 2006 Dec |
4 |
| 62 |
15970799 | Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. | 2005 Jul |
1 |
| 63 |
10601278 | A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. | 1999 Dec 24 |
1 |